IL165692A0 - Inhibitors of inflammatory gene activity and cholesterol biosynthesis - Google Patents

Inhibitors of inflammatory gene activity and cholesterol biosynthesis

Info

Publication number
IL165692A0
IL165692A0 IL16569203A IL16569203A IL165692A0 IL 165692 A0 IL165692 A0 IL 165692A0 IL 16569203 A IL16569203 A IL 16569203A IL 16569203 A IL16569203 A IL 16569203A IL 165692 A0 IL165692 A0 IL 165692A0
Authority
IL
Israel
Prior art keywords
inhibitors
gene activity
cholesterol biosynthesis
inflammatory gene
inflammatory
Prior art date
Application number
IL16569203A
Other languages
English (en)
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of IL165692A0 publication Critical patent/IL165692A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • C12N9/0073—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14) with NADH or NADPH as one donor, and incorporation of one atom of oxygen 1.14.13
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70567—Nuclear receptors, e.g. retinoic acid receptor [RAR], RXR, nuclear orphan receptors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/044—Hyperlipemia or hypolipemia, e.g. dyslipidaemia, obesity

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
IL16569203A 2002-06-13 2003-06-13 Inhibitors of inflammatory gene activity and cholesterol biosynthesis IL165692A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38791502P 2002-06-13 2002-06-13
PCT/US2003/018651 WO2003106632A2 (en) 2002-06-13 2003-06-13 Inhibitors of inflammatory gene activity and cholesterol biosynthesis

Publications (1)

Publication Number Publication Date
IL165692A0 true IL165692A0 (en) 2006-01-15

Family

ID=29736382

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16569203A IL165692A0 (en) 2002-06-13 2003-06-13 Inhibitors of inflammatory gene activity and cholesterol biosynthesis

Country Status (4)

Country Link
AU (1) AU2003247525A1 (xx)
IL (1) IL165692A0 (xx)
WO (1) WO2003106632A2 (xx)
ZA (1) ZA200500296B (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060233873A1 (en) * 2003-01-24 2006-10-19 Julien Meissonnier Dispersion of taste masked crystals or granules of active substances, chewable soft capsules filled with said dispersion, and process for preparing same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030083484A1 (en) * 2001-07-31 2003-05-01 Crooke Rosanne M. Antisense modulation of short heterodimer partner-1 expression
US20030109467A1 (en) * 2001-11-15 2003-06-12 Isis Pharmaceuticals Inc. Antisense modulation of human FXR expression

Also Published As

Publication number Publication date
WO2003106632A2 (en) 2003-12-24
WO2003106632A3 (en) 2004-06-10
AU2003247525A1 (en) 2003-12-31
ZA200500296B (en) 2005-11-01

Similar Documents

Publication Publication Date Title
EP1496906A4 (en) INHIBITORS OF AKT ACTIVITY
EP1494675A4 (en) HEMMER OF ACT ACTIVITY
AU2003293132A8 (en) Integration of gene expression data and non-gene data
IL173174A0 (en) Inhibitors of akt activity
HK1085244A1 (en) Quantification of gene expression
PL376301A1 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 and type 2
AU2002251266A1 (en) Inhibitors of akt activity
EP1720855A4 (en) HEMMER OF ACT ACTIVITY
EP1784175A4 (en) INHIBITORS OF ACT ACTIVITY
EP1737861A4 (en) INHIBITORS OF AKT ACTIVITY
EP1827436A4 (en) ACTIVITY INHIBITORS AKT
AU2003256249A8 (en) Compositions and methods for suppressing eukaryotic gene expression
EP1507756A4 (en) CCR9 INHIBITORS AND USE THEREOF
EP1490373A4 (en) INHIBITORS OF NUCLEOSIDE PHOSPHORYLASES AND NUCLEOSIDASES
AU2003287254A1 (en) Inhibition of gene expression using rna interfering agents
EP1824849A4 (en) INHIBITORS OF AKT ACTIVITY
AU2003275195A1 (en) INHIBITORS OF 11Beta-HYDROXYSTEROID DEHYDROGENASE AND USES THEREFOR
EP1613628A4 (en) REVERSIBLE INHIBITORS OF S-ADENOSYL-L-HOMOCYSTEIN HYDROLASE AND ITS USES
EP1560925A4 (en) INHIBITORS OF INFLAMMATORY GENE ACTIVITY AND CHOLESTEROL SYNTHESIS
EP1682115A4 (en) HIF-1 HEMMER AND APPLICATION METHOD THEREFOR
IL167406A0 (en) Lipophilic diesters of chelatingagent for inhibition of enzyme activity
IL164267A0 (en) Piperazinyl-or piperidinylamine-sulfamic acid amides as inhibitors of steroid sulfatase
IL165692A0 (en) Inhibitors of inflammatory gene activity and cholesterol biosynthesis
AU2003256280A1 (en) Methods of delivering gene therapy agents
AU2002359403A8 (en) Methods and compositions for regulation of gene expression through modulation of mrna turnover